Medical Science Liaison

Before reading the job post, we encourage you to watch this video about our company. It gives you an inside look at how we started, the team and culture that made us successful, and where we're going. It's easy to read a job post and apply, but people often wonder about the culture and whether they would fit in. If you want to call Harrow your home and genuinely want to be part of a family and something big, then we encourage you to click this link and get to know us.

 

Who is Harrow?

Harrow (Nasdaq: HROW) is a leading U.S. ophthalmic-focused pharmaceutical company. The Company was founded and continues operating based on the highest corporate values. Members of our Harrow Family often express their pride in being a part of our commitment to (1) innovation, (2) patient access to and affordability of our medicines, and (3) our track record of having never turned down an ophthalmologist doing mission work around the world – providing free medicines in support of mission work aimed at giving or maintaining the gift of sight to those most in need.

At Harrow, we foster our individual and collective entrepreneurial and creative spirits. We focus on pursuing opportunities for drug candidates in underserved markets. We are data-driven and use our access to real-world clinical experience to lower the investment risks of our work. We concentrate on the commercial appeal of high-value assets, and our objective is to seek to make paradigm-shifting medicines available to patients as soon as possible. Our approach to finding high-value opportunities and balancing risk with real-world experience can deliver exceptional value for all our stakeholders.

Harrow’s ophthalmic pharmaceutical portfolio is one of the most comprehensive in the industry, including:

• IHEEZO:
•  A broad Dry Eye Disease product line, led by VEVYE® and bolstered by well-known adjacent ocular surface disease products such as FLAREX® and TOBRADEX® ST;
• TRIESENCE®:
•  A Specialty Anterior Segment product line, which includes various high-need and utility products such as ILEVRO®, NEVANAC®, and VERKAZIA®;
• ImprimisRx is the nation’s leading ophthalmology-focused compound pharmacy, including an FDA-registered and FDA-inspected 503B outsourcing facility and a 50-state mail-order pharmacy. The division of Harrow serves as an innovation hub and plays a vital role in Harrow’s mission to help patients maintain their gift of sight.

Medical Science Liaison “MSL’s” Summary

 

Medical Science Liaisons “MSLs” serve as a strategic link between Harrow and our Scientific Partners as they are expected to develop and maintain peer-to-peer relationships with Key Opinion Leaders (KOLs) in the field of Ophthalmology and Optometry. The MSL's strategically support the development and appropriate use/adoption of Harrow pharmaceutical products through evidence-based scientific exchange and by seeking external insights to inform further and shape the company’s understanding of the products, therapeutic area, and clinical practice. Additionally, the MSLs provide general medical/healthcare information in given therapeutic area(s) to practitioners and internal Harrow associates.

MSLs also respond to unsolicited requests for medical information, scientific exchange/insights, detailed working knowledge of Harrow pharmaceutical products, current medical/scientific research, and publications. The MSL ensures appropriate dissemination of clinical and scientific information regarding marketed and pipeline products in a timely, compliant, and customer-focused manner. The MSL will also support or lead authorship of scientific materials, including papers, presentations, and other content.

Responsibilities:

• Medical Support & Key Opinion Leader (KOL) Relationship Development -Develop a strong understanding of the future needs of ECPs (Eye care professionals and other prescribers.
• Liaise and provide up-to-date medical support to healthcare associations to ensure an evidence-based understanding of Harrow products relative to medical guidelines and medical evidence/health economic information.
• Provide non-promotional speaker training to HCPs to support education to the healthcare community about therapies developed and commercialized.
• Identify national, regional, and local KOLs; develop peer-to-peer scientific relationships with KOLs and decision-makers to expand scientific partnership opportunities; and gain their advocacy.
• Assure thoughtful and informed exchange of current medical information and data related to Harrow products and selected areas of therapeutic interest with KOLs.
• Act as an interface between Medical Expert/ HCP and Harrow to provide up-to-date suppor